Abstract
Malignant otitis externa (MOE) is a rare, invasive infection of the temporal bone that arises in the external auditory canal. Most cases are due to Pseudomonas and occur in older diabetic patients. Untreated infection can extend to surrounding soft tissues and bones (temporomandibular joint , nasopharynx, petrous apex , skull base). The infection is subacute to chronic in presentation but potentially life-threatening. The correct diagnosis is often missed for weeks to months because the clinician is unfamiliar with the signs and symptoms of MOE. The high mortality rate seen in early series prompted the adjective “malignant,” but recent series have demonstrated that cure is possible in all cases if MOE is diagnosed early and treated appropriately. This chapter reviews the clinical features, diagnostic evaluation, and treatment of MOE.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Meltzer PE, Kelemen G. Pyocyaneous osteomyelitis of the temporal bone, mandible and zygoma. Laryngoscope. 1959;69:1300–16.
Chandler JR. Malignant external otitis. Laryngoscope. 1968;78:1257–94.
Cohen D, Friedman P. The diagnostic criteria of malignant external otitis. J Laryngol Otol. 1987;101:216–21.
Sudhoff H, Rajagopal S, Mani N, et al. Usefulness of CT scans in malignant external otitis: effective tool for the diagnosis, but of limited value in predicting outcome. Eur Arch Otorhinolaryngol. 2008;265:53–6.
Stroman DW, Roland PS, Dohar J, Burt W. Microbiology of normal external auditory canal. Laryngoscope. 2001;111(11 Pt 1):2054–9.
Salit IE, Miller B, Wigmore M, Smith JA. Bacterial flora of the external canal in diabetics and non-diabetics. Laryngoscope. 1982;92(6 Pt 1):672–3.
Mena KD, Gerba CP. Risk assessment of Pseudomonas aeruginosa in water. Rev Environ Contam Toxicol. 2009;201:71–115.
Walker J, Moore G. Pseudomonas aeruginosa in hospital water systems: biofilms, guidelines, and practicalities. J Hosp Infect. 2015;89:324–7.
Grandis J, Stoehr G, Yu VL, et al. Aural irrigation with water: a potential pathogenic mechanism for inducing malignant external otitis? Arch Otol Rhinol Laryngol. 1990;99:117–9.
Zikk D, Rapoport Y, Himelfarb MZ. Invasive external otitis after removal of impacted cerumen by irrigation (letter). N Engl J Med. 1991;325:969–70.
Ford GR, Courteney-Harris RG. Another hazard of ear syringing: malignant otitis externa. J Laryngol Otol. 1990;104:709–10.
Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med. 1988;85:391–8.
Hamzany Y, Soudry E, Preis M, et al. Fungal malignant external otitis. J Infect. 2011;62(3):226–31.
Al-Noury K, Lotfy A. Computed tomography and magnetic resonance imaging findings before and after treatment of patients with malignant external otitis. Eur Arch Otorhinolaryngol. 2011;268:1727–34.
Chen YA, Chan KC, Chen CK, Wu CM. Differential diagnosis and treatment of necrotizing otitis externa: a report of 19 cases. Auris Naris Larynx. 2011;28:666–70.
Hobson CE, Moy JD, Byers KE, et al. Malignant otitis externa: evolving pathogens and implications for diagnosis and treatment. Otolaryngol Head Neck Surg. 2014;151:112–6.
Franco-Vidal V, Blanchet H, Bebear C, et al. Necrotizing external otitis: a report of 46 cases. Otol Neurotol. 2007;28:771–3.
Hariga I, Mardassi A, Belhaj Younes F, et al. Necrotizing otitis externa: 19 cases’ report. Eur Arch Otorhinolaryngol. 2010;267:1193–8.
Chin R, Roche P, Sigston E, Valance N. Malignant otitis externa: an Australian case series. Surgery. 2012;10:273–7.
Meade TK, Anari S, El Badawey MR, Zammit-Maempel I. Malignant otitis externa: case series. J Laryngol Otol. 2010;124:846–51.
Stevens SM, Lambert PR, Baker AB, Meyer TA. Malignant otitis externa: a novel stratification protocol for predicting treatment outcomes. Otol Neurotol. 2015;36:1492–8.
Pulcini C, Mahdyoun P, Cua E, et al. Antibiotic therapy in necrotizing external otitis: case series of 32 patients and review of the literature. Eur J Clin Microbiol Infect Dis. 2012;31:3287–94.
Lambor DV, Das CP, Goel HC, et al. Necrotising otitis externa: clinical profile and management protocol. J Laryngol Otol. 2013;127:1071–7.
Bhat V, Aziz A, Kumar Bhandary S, et al. Malignant otitis externa – a retrospective study of 15 patients treated in a tertiary healthcare center. Int Adv Otol. 2015;11:72–6.
Loh S, Loh WS. Malignant otitis externa: an Asian perspective on treatment outcomes and prognostic factors. Otolaryngol Head Neck Surg. 2013;148:991–6.
Karaman E, Yilmaz M, Ibrahimov M, et al. Malignant otitis externa. J Craniofac Surg. 2012;23:1748–51.
Weinroth SE, Schessel D, Tuazon CU. Malignant otitis externa in AIDS patients: case report and review of the literature. Ear Nose Throat J. 1994;73:772–8.
Rubin J, Yu VL, Stool SE. Malignant external otitis in children. J Pediatr. 1988;113:965–70.
Guerrero-Espejo A, Valenciano-Moreno I, Ramirez-Llorens R, Perez-Monteagudo P. Malignant otitis externa in Spain. Acta Otorrhinolaringol Esp. 2017;68:23–8.
Sylvester MJ, Sanghvi S, Patel VM, et al. Malignant otitis externa hospitalizations: analysis of patient characteristics. Laryngoscope. 2017;127(10):2328–36.
Chawdhary G, Liow N, Democratis J, Whiteside O. Necrotising (malignant) otitis externa in the UK: a growing problem. Review of five cases and analysis of national Hospital Episode Statistics trends. J Laryngol Otol. 2015;129:600–3.
Mardinger O, Rosen D, Minkow B, et al. Temporomandibular joint involvement in malignant external otitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:398–403.
Mani N, Sudhoff H, Rajagopal S, et al. Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope. 2007;117:907–10.
Stern Shavit S, Soudry E, Hamzany Y, Nageris B. Malignant external otitis: factors predicting patient outcomes. Am J Otolaryngol. 2016;37:425–30.
Omran AA, El Garem HF, Al Alem RK. Recurrent malignant otitis externa: management and outcome. Eur Arch Otorhinolaryngol. 2012;269:807–11.
Walton J, Coulson C. Fungal malignant otitis externa with facial nerve palsy: tissue biopsy aids diagnosis. Case Rep Otolaryngol. 2014;2014:192318.
Mion M, Bovo R, Marchese-Ragona R, Martini A. Outcome predictors of treatment effectiveness for fungal malignant external otitis: a systematic review. Acta Otorhinolaryngol Ital. 2015;35:307–13.
McLaren O, Potter C. Scedosporium apiospermum: a rare cause of malignant otitis externa. BMJ Case Rep. 2016;2016:bcr2016217015.
Rubin J, Curtin HD, Yu VL, Kamerer DB. Malignant external otitis: utility of CT in diagnosis and follow up. Radiology. 1990;174:391–4.
Mattucci KF, Setzen M, Galantich P. Necrotizing otitis externa occurring concurrently with epidermoid carcinoma. Laryngoscope. 1986;96:264-266.
Grandis JR, Hirsch BE, Yu VL. Simultaneous presentation of malignant external otitis and temporal bone cancer. Arch Otolaryngol Head Neck Surg. 1993;119:687–9.
al-Shihabi BA. Carcinoma of temporal bone presenting as malignant otitis externa. J Laryngol Otol. 1992;106(10):908.
Foden N, Burgess C, Damato S, Ramsden J. Concurrent necrotising otitis externa and adenocarcinoma of the temporal bone: a diagnostic challenge. BMJ Case Rep. 2013;2013:bcr2013009155. https://doi.org/10.1136/bcr-2013-009155.
Goh JPN, Karandikar A, Loke SC, Tan TY. Skull base osteomyelitis secondary to malignant otitis externa mimicking advanced nasopharyngeal cancer: MR imaging features at initial presentation. Am J Otolaryngol. 2017;38:466–71.
Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408–15.
Patterson TF, Thompson GR III, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1-e60.
Parize P, Chandesris MO, Lanternier F, et al. Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review. Antimicrob Agents Chemother. 2009;53:1048–53.
Maertens JA, Raad II, Marr KA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016;387(10020):760–9.
Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev. 2013:CD004617.
Rubin J, Stoehr G, Yu VL, et al. Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Arch Otolaryngol Head Neck Surg. 1989;115:1063–9.
Lang R, Goshen S, Kitzes-Cohen R, et al. Successful treatment of malignant external otitis with oral ciprofloxacin: report of experience with 23 patients. J Infect Dis. 1990;161:5357–540.
Doroghazi RM, Nadol JB, Hyslop NE, et al. Invasive external otitis. Report of 21 cases and review of the literature. Am J Med. 1981;71:603–14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Durand, M.L. (2018). Malignant Otitis Externa. In: Durand, M., Deschler, D. (eds) Infections of the Ears, Nose, Throat, and Sinuses. Springer, Cham. https://doi.org/10.1007/978-3-319-74835-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-74835-1_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74834-4
Online ISBN: 978-3-319-74835-1
eBook Packages: MedicineMedicine (R0)